Clinical Trial Update: Safety and Efficacy Study of Ethanol Locking to Prevent Central Line Infection in Premature Neonates [NA]

View source ↗

Summary

A clinical trial assessing ethanol locking to prevent central line infections in premature neonates was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Central Line-associated Bloodstream Infection
• Sepsis

Drugs mentioned

• Ethanol locking solution (ethanol)

Snippet

Sponsor: East Carolina University | Conditions: Infection Associated With Catheter, Bacteremia | NA | Status: TERMINATED